Status:
COMPLETED
Exercise Training and Inflammatory Mediators in COPD
Lead Sponsor:
Faculty of Medicine, Sousse
Conditions:
COPD
Eligibility:
MALE
40-75 years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020\[1\]. COPD is a common, preventable treatable disease t...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020. COPD is a common, preventable treatable disease that i...
Eligibility Criteria
Inclusion
- COPD diagnosed by pulmonary function testing
- Clinically stable
- Abscence of other obstructive diseases
- Signed written consent
Exclusion
- Neuromuscular diseases -Severe psychiatric, neurologic or musculoskeletal conditions and /or instable--- --
- cardiovascular diseases.
- Contre-indications to physical therapy
- Acute exacerbations a month before the intervention
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 27 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03853174
Start Date
January 1 2019
End Date
April 27 2019
Last Update
December 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amal Acheche
Sousse, Tunisia, 4002